selenomethionine has been researched along with Skin Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahsan, H; Anton, K; Argos, M; Baron, JA; Dignam, J; Harjes, J; Hossain, Z; I Patwary, T; Islam, T; Jasmine, F; K Hore, S; Kamal, M; Khan, R; Kibriya, MG; La Porte, P; Parvez, F; Quasem, I; Rahman, M; Rakibuz-Zaman, M; Sarwar, G; Shea, CR; T Haider, A; Yunus, M | 1 |
| Burke, KE; Combs, GF; Commisso, J; Keen, CL; Nakamura, RM; Wang, Y; Wei, H; Zhou, X | 1 |
| Gangapurkar, B; Jariwalla, RJ; Nakamura, D | 1 |
| Burke, KE; Clive, J; Combs, GF; Nakamura, RM | 1 |
| Ahmed, A; Ahsan, H; Argos, M; Jasmine, F; Kibriya, MG; Parvez, F; Rakibuz-Zaman, M; Verret, WJ | 1 |
| Chung, AS; Kim, A; Oh, JH; Park, JM | 1 |
| Savel'eva, OP | 1 |
| Clark, LC; Marshall, JR | 1 |
| Abu-Libdeh, H; Bhuyan, KC; Burke, KE; Combs, GF; Gross, EG | 1 |
2 trial(s) available for selenomethionine and Skin Neoplasms
| Article | Year |
|---|---|
Baseline comorbidities in a skin cancer prevention trial in Bangladesh.
Topics: Adult; Aged; alpha-Tocopherol; Anticarcinogenic Agents; Antioxidants; Arsenic Poisoning; Bangladesh; Double-Blind Method; Female; Humans; Male; Middle Aged; Selenomethionine; Skin Neoplasms | 2013 |
Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia.
Topics: Anticarcinogenic Agents; Arizona; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dietary Supplements; Double-Blind Method; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatectomy; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenomethionine; Skin Neoplasms | 2001 |
7 other study(ies) available for selenomethionine and Skin Neoplasms
| Article | Year |
|---|---|
The effects of topical L-selenomethionine on protection against UVB-induced skin cancer when given before, during, and after UVB exposure.
Topics: Administration, Cutaneous; Animals; Anticarcinogenic Agents; Drug Administration Schedule; Mice; Mice, Hairless; Neoplasms, Radiation-Induced; Selenomethionine; Skin Neoplasms; Time Factors; Ultraviolet Rays | 2014 |
Differential sensitivity of various human tumour-derived cell types to apoptosis by organic derivatives of selenium.
Topics: Adenocarcinoma; Adolescent; Adult; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Cysteine; Epithelial Cells; Female; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Neuroectodermal Tumors, Primitive, Peripheral; Organoselenium Compounds; Selenium Compounds; Selenocysteine; Selenomethionine; Skin Neoplasms | 2009 |
Effects of topical L-selenomethionine with topical and oral vitamin E on pigmentation and skin cancer induced by ultraviolet irradiation in Skh:2 hairless mice.
Topics: Administration, Oral; Administration, Topical; Analysis of Variance; Animals; Disease Models, Animal; Female; Mice; Mice, Hairless; Neoplasms, Radiation-Induced; Random Allocation; Reference Values; Selenomethionine; Sensitivity and Specificity; Skin; Skin Neoplasms; Skin Pigmentation; Tissue Distribution; Treatment Outcome; Ultraviolet Rays; Vitamin E | 2003 |
Changes in gene expression profiles in response to selenium supplementation among individuals with arsenic-induced pre-malignant skin lesions.
Topics: Antioxidants; Arsenic; Arsenic Poisoning; Bangladesh; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Precancerous Conditions; RNA; Selenomethionine; Skin Neoplasms; Water Pollutants, Chemical | 2007 |
Methylselenol generated from selenomethionine by methioninase downregulates integrin expression and induces caspase-mediated apoptosis of B16F10 melanoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carbon-Sulfur Lyases; Caspase Inhibitors; Caspases; Cell Adhesion; Cell Cycle; Cell Proliferation; Cell Shape; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Extracellular Matrix; Focal Adhesion Kinase 1; I-kappa B Proteins; Integrins; Melanoma, Experimental; Methanol; Mice; Organometallic Compounds; Organoselenium Compounds; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C-delta; Proto-Oncogene Proteins c-akt; Selenomethionine; Signal Transduction; Skin Neoplasms; Sodium Selenite | 2007 |
[Studies of the properties of experimental melanoma using 75Se-methionine].
Topics: Animals; Female; Melanoma; Mice; Mice, Inbred C57BL; Radionuclide Imaging; Selenium; Selenomethionine; Skin; Skin Neoplasms | 1984 |
The effects of topical and oral L-selenomethionine on pigmentation and skin cancer induced by ultraviolet irradiation.
Topics: Administration, Cutaneous; Administration, Oral; Analysis of Variance; Animals; Eye; Female; Mice; Mice, Hairless; Mice, Inbred BALB C; Neoplasms, Radiation-Induced; Proportional Hazards Models; Selenomethionine; Skin Neoplasms; Skin Pigmentation; Ultraviolet Rays | 1992 |